Log In
Print
BCIQ
Print
Print this Print this
 

Z123212, Z212

  Manage Alerts
Collapse Summary General Information
Company Epirus Biopharmaceuticals Inc.
DescriptionSmall molecule that blocks the Nav1.7 (SCN9A) and Nav1.8 (PN3; SCN10A) sodium channels
Molecular Target Nav1.7 (SCN9A) ; Nav1.8 (PN3) (SCN10A)
Mechanism of ActionNa channel blocker
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat pain
Regulatory Designation

Partner

AnaBios Corp.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$17.2M

0

$17.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today